Long-term analysis of the WHO-defined molecular subgroups of high-risk grade II gliomas treated with radiation and temozolomide on NRG Oncology/RTOG 0424.

Erica Hlavin Bell,Stephanie L. Pugh,Barbara Fisher,Glenn J. Lesser,David R. Macdonald,Jessica Fleming,Joseph P. McElroy,Aline Paixão Becker,C.Leland Rogers,Thomas J. Doyle,Maria Werner-Wasik,Jean-Paul Bahary,Michael Yu,David DSouza,Nadia N. Laack,P Sneed,Young Kwok,Steven P. Howard,Minesh P. Mehta,Arnab Chakravarti

Long-term analysis of the WHO-defined molecular subgroups of high-risk grade II gliomas treated with radiation and temozolomide on NRG Oncology/RTOG 0424.

2020

2518Background: This study sought to evaluate the prognostic significance of the three WHO-defined molecular glioma subgroups (IDHwt, IDHmt/non-codel, and IDHmt/codel) in NRG Oncology/RTOG 0424, a ...

Keywords:

Temozolomide
Oncology
Internal medicine
Medicine
Glioma

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations